Aktie A113YC TALKMED GROUP LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen TalkMed Group Limited

Aktien

A113YC

SG2G61000003

5G3

Markt geschlossen - Singapore S.E.
Andere Börsenplätze
 10:59:47 30.04.2024 		% 5 Tage % 1. Jan.
0.41 SGD -2.38% Intraday Chart für TalkMed Group Limited -1.20% +7.89%
20.02. TalkMed Group Limited meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 TalkMed Group Limited kündigt Änderungen im Management an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
TalkMed Group Limited Approves Final One-Tier Tax-Exempt Dividend for the Financial Year Ended 31 December 2023
TalkMed Reaches Final Settlement in Mediation Related to Claims in Stem Med Stake Disposal
TalkMed Group Awards 1.1 Million New Shares
TalkMed's H2 Attributable Profit Falls on Wider Impairment Loss
Talkmed Group Limited Proposes Tax Exempt (One-Tier) Final Dividend for the Financial Year Ended 31 December 2023, Payable on 10 May 2024
TalkMed Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
TalkMed Group Grants Nearly 8 Million Share Awards Under Performance Share Plan
TalkMed Group Limited Announces Management Changes
TalkMed Group Limited Announces Re-Designation of Leong Ching Ching from Non-Executive Director to Independent Non-Executive Director and Appoints as Chairman of the Remuneration Committee, Effective January 1, 2024
TalkMed Group Limited Announces Re-Designation of S. Chandra Das from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024
TalkMed Group Limited Announces Re-Designation of Sitoh Yih Pin from Independent Non-Executive Director to Non-Independent Non-Executive Director, Effective 1 January 2024
Talkmed Group Limited Appoints Khoo Kei Siong as Alternate Director to Ang Peng Tiam, Effective January 1, 2024
TalkMed Group Limited Appoints Dr Tan Khai Tong as Independent Non-Executive Director, Member of the Remuneration Committee, Effective January 1, 2024
TalkMed Group Limited Appoints Peter Sim Swee Yam as Independent Non-Executive Director, Chairman of the Nominating Committee, Member of the Audit and Risk Committee, Effective January 1, 2024
TalkMed Group Limited Appoints Lam Kok Shang as Independent Non-Executive Director, Chairman of the Audit and Risk Committee, Member of the Nominating Committee, Effective January 1, 2024
TalkMed Group Issues New Shares Upon Vesting of Share Awards
TalkMed Group Issues New Shares Upon Vesting of Share Awards
Singapore Stocks Track Global Gains to Close Higher; Delfi Shares Jump 3% on Higher H1 Profit, Revenue
TalkMed Group's Attributable Profit Zooms 18% in H1
TalkMed Group Limited Declares Tax Exempt (One-Tier) Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 22 August 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A113YC Aktie
  4. Nachrichten TalkMed Group Limited
  5. Andere Sprachen